Persistent twitching of the latissimus dorsi muscle after a posterolateral thoracotomy

ANZ Journal of Surgery

Volumn 72, Issue 9, 2002, Pages 680-681

  Hao, Long ^a   Clarke, C Peter ^a,b  

^a AUSTIN HEALTH   (Australia)

^b NONE   (Australia)

Author keywords

Complications of thoracotomy; Latissimus dorsi; Muscle twitching

Indexed keywords

ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; BOTULINUM TOXIN; SEDATIVE AGENT; SPASMOLYTIC AGENT;

ADULT; ANGINA PECTORIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; HUMAN; LATISSIMUS DORSI MUSCLE; LUNG SQUAMOUS CELL CARCINOMA; MALE; MUSCLE DENERVATION; MUSCLE TWITCH; POSTOPERATIVE COMPLICATION; SURGICAL TECHNIQUE; THORACOTOMY; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; MUSCLE, SKELETAL; THORACOTOMY;

EID: 0036379810     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-2197.2002.02501.x     Document Type: Article

References (4)

1. Snobl D, Binaghi LE, Zenker W. Microarchitecture and innervation of the human Latissimus Dorsi Muscle. J. Reconstr. Microsurg. 1998; 14: 171-7.
2. Blitzer A, Sulica L. Botulinum toxin: Basic science and clinical use in otolaryngology. Laryngoscope 2001; 111: 218-28.
3. Kuwabara S, Fukutake T, Kasahata N, Shimoe Y, Yamanaka I, Hirayama K. Associated movement as a sequel to thoracotomy: Aberrant regeneration to the latissimus dorsi muscle. Mov. Disord. 1995; 10: 788-90.
4. Titley OG, Spyrou GE, Fatah MF. Preventing seroma in the latissimus dorsi flap donor site. Br. J. Plast. Surg. 1997; 50: 106-8.